Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
08 2022
Historique:
revised: 13 05 2022
received: 18 10 2021
accepted: 16 05 2022
pubmed: 25 5 2022
medline: 28 7 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

This study aimed to assess whether non-invasive brain stimulation with transcranial alternating current stimulation at gamma-frequency (γ-tACS) applied over the precuneus can improve episodic memory and modulate cholinergic transmission by modulating cerebral rhythms in early Alzheimer's disease (AD). In this randomized, double-blind, sham controlled, crossover study, 60 AD patients underwent a clinical and neurophysiological evaluation including assessment of episodic memory and cholinergic transmission pre and post 60 minutes treatment with γ-tACS targeting the precuneus or sham tACS. In a subset of 10 patients, EEG analysis and individualized modelling of electric field distribution were carried out. Predictors to γ-tACS efficacy were evaluated. We observed a significant improvement in the Rey Auditory Verbal Learning (RAVL) test immediate recall (p < 0.001) and delayed recall scores (p < 0.001) after γ-tACS but not after sham tACS. Face-name associations scores improved with γ-tACS (p < 0.001) but not after sham tACS. Short latency afferent inhibition, an indirect measure of cholinergic transmission, increased only after γ-tACS (p < 0.001). ApoE genotype and baseline cognitive impairment were the best predictors of response to γ-tACS. Clinical improvement correlated with the increase in gamma frequencies in posterior regions and with the amount of predicted electric field distribution in the precuneus. Precuneus γ-tACS, able to increase γ-power activity on the posterior brain regions, showed a significant improvement of episodic memory performances, along with restoration of intracortical excitability measures of cholinergic transmission. Response to γ-tACS was dependent on genetic factors and disease stage. ANN NEUROL 2022;92:322-334.

Identifiants

pubmed: 35607946
doi: 10.1002/ana.26411
pmc: PMC9546168
doi:

Substances chimiques

Cholinergic Agents 0

Banques de données

ClinicalTrials.gov
['NCT04842955']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-334

Informations de copyright

© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Sci Adv. 2020 Sep 2;6(36):
pubmed: 32917605
Nature. 2016 Aug 31;537(7618):50-6
pubmed: 27582220
Neuropharmacology. 2017 Feb;113(Pt A):45-59
pubmed: 27647493
Neuroimage Clin. 2016 Jan 20;11:106-115
pubmed: 26937378
Lancet Neurol. 2011 Mar;10(3):241-52
pubmed: 21349439
Front Hum Neurosci. 2018 May 25;12:211
pubmed: 29887799
Front Hum Neurosci. 2016 May 25;10:245
pubmed: 27252642
Alzheimers Dement (N Y). 2020 Apr 07;6(1):e12005
pubmed: 32313830
J Neurosci. 2013 Jul 3;33(27):11262-75
pubmed: 23825429
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Neuroimage. 2018 Apr 1;169:302-311
pubmed: 29277405
Ann Neurol. 2016 Sep;80(3):472-6
pubmed: 27438089
Clin Neurophysiol. 2013 May;124(5):837-50
pubmed: 23098644
Ann Neurol. 2020 Mar;87(3):394-404
pubmed: 31925823
Nature. 2016 Dec 7;540(7632):230-235
pubmed: 27929004
Hippocampus. 2004;14(7):919-30
pubmed: 15382260
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050
pubmed: 32695874
Brain Stimul. 2015 Mar-Apr;8(2):260-8
pubmed: 25499037
Brain Stimul. 2020 Mar - Apr;13(2):386-392
pubmed: 31787557
Expert Rev Neurother. 2015 Feb;15(2):145-67
pubmed: 25547149
Brain Stimul. 2020 Nov - Dec;13(6):1796-1799
pubmed: 33045404
Science. 2021 Apr 2;372(6537):
pubmed: 33795429
J Psychiatr Res. 2021 Sep;141:248-256
pubmed: 34256276
Psychophysiology. 2000 Mar;37(2):163-78
pubmed: 10731767
Int J Psychophysiol. 2016 May;103:88-102
pubmed: 25660305
Arch Neurol. 2001 Feb;58(2):225-30
pubmed: 11176960
Neurobiol Aging. 2005 Feb;26(2):165-71
pubmed: 15582746
Front Hum Neurosci. 2016 Dec 27;10:668
pubmed: 28082887
J Physiol. 2000 Mar 1;523 Pt 2:503-13
pubmed: 10699092
J Neurosci. 2016 May 11;36(19):5328-37
pubmed: 27170129
Front Aging Neurosci. 2018 Jan 24;10:6
pubmed: 29416508
eNeuro. 2019 Oct 16;6(5):
pubmed: 31591137
Brain. 2018 Jul 1;141(7):1917-1933
pubmed: 29850777
Neuropsychologia. 2011 Jul;49(9):2776-83
pubmed: 21689670
Aging Clin Exp Res. 2012 Jun;24(3):218-26
pubmed: 21691143
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Brain. 2006 Mar;129(Pt 3):564-83
pubmed: 16399806
Brain Stimul. 2021 May-Jun;14(3):531-540
pubmed: 33762220
Front Hum Neurosci. 2013 Jun 14;7:279
pubmed: 23785325
Clin Neurophysiol. 2016 Feb;127(2):1031-1048
pubmed: 26652115
Cell. 2014 May 8;157(4):845-57
pubmed: 24768692
Trends Cogn Sci. 2005 Sep;9(9):445-53
pubmed: 16054861
Front Hum Neurosci. 2013 Jun 28;7:317
pubmed: 23825454
Neuron. 2019 Jun 5;102(5):929-943.e8
pubmed: 31076275
J Alzheimers Dis. 2018;65(1):221-230
pubmed: 30010131
J Clin Neurophysiol. 2001 Mar;18(2):178-84
pubmed: 11435810
Brain Stimul. 2020 May - Jun;13(3):686-693
pubmed: 32289698
Front Neurol. 2021 May 20;12:598135
pubmed: 34093384
Clin Neurophysiol. 2020 Nov;131(11):2691-2699
pubmed: 33002731
Lancet Neurol. 2015 Sep;14(9):926-944
pubmed: 26213339
Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):673-701
pubmed: 32520597
Neurobiol Learn Mem. 2021 Jul;182:107444
pubmed: 33895350
Cell. 2019 Apr 4;177(2):256-271.e22
pubmed: 30879788
Neuroimage. 2003 Dec;20(4):1934-43
pubmed: 14683699
J Man Manip Ther. 2012 Aug;20(3):160-6
pubmed: 23904756
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42
pubmed: 10811879
Neuropharmacology. 2010 Nov;59(6):437-43
pubmed: 20600173
NeuroRehabilitation. 2019;45(3):369-378
pubmed: 31796701
J Alzheimers Dis. 2016 Jul 1;53(4):1375-88
pubmed: 27392866
Neurobiol Aging. 2012 Jul;33(7):1481.e13-23
pubmed: 22227005
Brain Stimul. 2020 Jul - Aug;13(4):998-999
pubmed: 32330606

Auteurs

Alberto Benussi (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Valentina Cantoni (V)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Mario Grassi (M)

Department of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.

Lucie Brechet (L)

Functional Brain Mapping Laboratory, Department of Fundamental Neuroscience, University of Geneva, Geneva, Switzerland.

Christoph M Michel (CM)

Functional Brain Mapping Laboratory, Department of Fundamental Neuroscience, University of Geneva, Geneva, Switzerland.
Center for Biomedical Imaging (CIBM), Lausanne, Switzerland.

Abhishek Datta (A)

Research & Development, Soterix Medical, Inc., New York, USA.

Chris Thomas (C)

Research & Development, Soterix Medical, Inc., New York, USA.

Stefano Gazzina (S)

Neurophysiology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Maria Sofia Cotelli (MS)

Neurology Unit, Valle Camonica Hospital, Brescia, Italy.

Marta Bianchi (M)

Neurology Unit, Valle Camonica Hospital, Brescia, Italy.

Enrico Premi (E)

Stroke Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Yasmine Gadola (Y)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Maria Cotelli (M)

Neuropsychology Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Marta Pengo (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Federica Perrone (F)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Maria Scolaro (M)

Neurophysiology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Silvana Archetti (S)

Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili Brescia, Brescia, Italy.

Eino Solje (E)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.
Neuro center, Neurology, Kuopio University Hospital, Kuopio, Finland.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Alvaro Pascual-Leone (A)

Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
Hinda and Arthur Marcus Institute for Aging Research and Deanna and Sidney Wolk Center for Memory Health, Hebrew SeniorLife, Boston, MA, USA.
Guttmann Brain Health Institut, Barcelona, Spain.

Barbara Borroni (B)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH